Loading...
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
Cost-effectiveness analyses (CEAs) alongside randomised controlled trials (RCTs) are increasingly designed to collect resource use and preference-based health status data for the purpose of healthcare technology assessment. However, because of the way these measures are collected, they are prone to...
Na minha lista:
| Udgivet i: | Pharmacoecon Open |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691848/ https://ncbi.nlm.nih.gov/pubmed/29442336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-017-0015-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|